Neil J Stewart1, General Leung1, Graham Norquay1, Helen Marshall1, Juan Parra-Robles1, Philip S Murphy2, Rolf F Schulte3, Charlie Elliot4,5, Robin Condliffe4,5, Paul D Griffiths1, David G Kiely4,5, Moira K Whyte4, Jan Wolber1,6, Jim M Wild1. 1. Academic Unit of Radiology, University of Sheffield, Royal Hallamshire Hospital, Sheffield, United Kingdom. 2. Clinical Imaging, GlaxoSmithKline, Brentford, United Kingdom. 3. GE Global Research, Garching, Germany. 4. Academic Directorate of Respiratory Medicine, University of Sheffield, Royal Hallamshire Hospital, Sheffield, United Kingdom. 5. Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals, Royal Hallamshire Hospital, Sheffield, United Kingdom. 6. Medical Diagnostics, GE Healthcare, Amersham, United Kingdom.
Abstract
PURPOSE: To assess the sensitivity of the hyperpolarized 129 Xe chemical shift saturation recovery (CSSR) technique for noninvasive quantification of changes to lung microstructure and function in idiopathic pulmonary fibrosis (IPF) and systemic sclerosis (SSc). METHODS: Ten healthy volunteers, four subjects with SSc and four with IPF were scanned at 1.5 T. A CSSR pulse sequence was implemented using binomial-composite radiofrequency pulses to monitor 129 Xe magnetization in tissues and blood plasma (T/P) and red blood cells (RBCs). The dynamics of 129 Xe uptake into these compartments were fitted with three existing analytical models of gas diffusion to extract parameters of lung physiology. These parameters were quantitatively compared between models. RESULTS: Uptake of xenon into the pulmonary capillaries was impaired in subjects with IPF and SSc. Statistically significant septal thickening was measured by 129 Xe CSSR in IPF patients. Preliminary data suggests age-dependent alterations to septal thickness in healthy volunteers. These findings were reproduced using each of the literature models. CSSR-derived parameters were compared with gold-standard indicators of pulmonary function; diffusing capacity of carbon monoxide and pulmonary transit-time. CONCLUSIONS: CSSR with hyperpolarized 129 Xe is sensitive to pathology-induced degradation of lung structure/function and shows promise for quantification of disease severity and monitoring treatment response. Magn Reson Med 74:196-207, 2015.
PURPOSE: To assess the sensitivity of the hyperpolarized 129 Xe chemical shift saturation recovery (CSSR) technique for noninvasive quantification of changes to lung microstructure and function in idiopathic pulmonary fibrosis (IPF) and systemic sclerosis (SSc). METHODS: Ten healthy volunteers, four subjects with SSc and four with IPF were scanned at 1.5 T. A CSSR pulse sequence was implemented using binomial-composite radiofrequency pulses to monitor 129 Xe magnetization in tissues and blood plasma (T/P) and red blood cells (RBCs). The dynamics of 129 Xe uptake into these compartments were fitted with three existing analytical models of gas diffusion to extract parameters of lung physiology. These parameters were quantitatively compared between models. RESULTS: Uptake of xenon into the pulmonary capillaries was impaired in subjects with IPF and SSc. Statistically significant septal thickening was measured by 129 Xe CSSR in IPF patients. Preliminary data suggests age-dependent alterations to septal thickness in healthy volunteers. These findings were reproduced using each of the literature models. CSSR-derived parameters were compared with gold-standard indicators of pulmonary function; diffusing capacity of carbon monoxide and pulmonary transit-time. CONCLUSIONS: CSSR with hyperpolarized 129 Xe is sensitive to pathology-induced degradation of lung structure/function and shows promise for quantification of disease severity and monitoring treatment response. Magn Reson Med 74:196-207, 2015.
Authors: Andrew D Hahn; Jeff Kammerman; Michael Evans; Wei Zha; Robert V Cadman; Keith Meyer; Nathan Sandbo; Sean B Fain Journal: J Magn Reson Imaging Date: 2019-04-10 Impact factor: 4.813
Authors: Scott H Robertson; Rohan S Virgincar; Elianna A Bier; Mu He; Geoffrey M Schrank; Rose Marie Smigla; Craig Rackley; H Page McAdams; Bastiaan Driehuys Journal: Magn Reson Med Date: 2016-11-08 Impact factor: 4.668
Authors: Lukas Ebner; Jeff Kammerman; Bastiaan Driehuys; Mark L Schiebler; Robert V Cadman; Sean B Fain Journal: Eur J Radiol Date: 2016-09-16 Impact factor: 3.528
Authors: Peter J Niedbalski; Elianna A Bier; Ziyi Wang; Matthew M Willmering; Bastiaan Driehuys; Zackary I Cleveland Journal: J Appl Physiol (1985) Date: 2020-06-18
Authors: Kai Ruppert; Faraz Amzajerdian; Yi Xin; Hooman Hamedani; Luis Loza; Tahmina Achekzai; Ian F Duncan; Harrilla Profka; Yiwen Qian; Mehrdad Pourfathi; Stephen Kadlecek; Rahim R Rizi Journal: Magn Reson Med Date: 2020-06-18 Impact factor: 4.668
Authors: Jennifer M Wang; Scott H Robertson; Ziyi Wang; Mu He; Rohan S Virgincar; Geoffry M Schrank; Rose Marie Smigla; Thomas G O'Riordan; John Sundy; Lukas Ebner; Craig R Rackley; Page McAdams; Bastiaan Driehuys Journal: Thorax Date: 2017-08-31 Impact factor: 9.139
Authors: Elianna A Bier; Scott H Robertson; Geoffry M Schrank; Craig Rackley; Joseph G Mammarappallil; Sudarshan Rajagopal; H Page McAdams; Bastiaan Driehuys Journal: NMR Biomed Date: 2018-11-20 Impact factor: 4.044